Skip to content
20-F

Annual Report (Foreign)

Akso Health Group AHG

0001013762-24-002658

← back to feed
Filed
Jul 30, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 31, 2024 437.17M sh
Stockholders Equity FY 2024 · Mar 31, 2023 $8.73M
Current Liabilities FY 2024 · Mar 31, 2023 $11.62M
Total Liabilities FY 2024 · Mar 31, 2023 $11.62M
Current Assets FY 2024 · Mar 31, 2023 $20.46M
Total Assets FY 2024 · Mar 31, 2023 $20.46M
Shares Diluted FY 2024 · Mar 31, 2022 59.61M sh
Operating Cash Flow FY 2024 · Mar 31, 2022 −$8.63M
Eps Diluted FY 2024 · Mar 31, 2022 −$0.28
Eps Basic FY 2024 · Mar 31, 2022 −$0.28
Net Income FY 2024 · Mar 31, 2022 −$16.85M
Operating Income restated FY 2024 · Mar 31, 2022 −$3.26M
Gross Profit restated FY 2024 · Mar 31, 2022 $605.13K